Dr Phillip Bergen - Researcher Profile

Biography

Position

Lecturer
Faculty of Pharmacy and Pharmaceutical Sciences
 
Drug Delivery, Disposition and Dynamics
Monash Institute of Pharmaceutical Sciences

 

Qualifications

DOCTOR OF PHILOSOPHY

Institution: Monash University

Year awarded: 2012

BACHELOR OF PHARMACY (HONS)

Institution: Monash University

Year awarded: 2002

BACHELOR OF SCIENCE

Institution: Monash University

Year awarded: 1995

Publications

Journal Articles

Bergen, P.J., Landersdorfer, C.B., Lee, H.J., Li, J., Nation, R.L., 2012, 'Old' antibiotics for emerging multidrug-resistant bacteria, Current Opinion In Infectious Diseases [P], vol 25, issue 6, Lippincott Williams & Wilkins, Philadelphia, Pennsylvania USA, pp. 626-633.

Bergen, P.J., Landersdorfer, C.B., Zhang, J., Zhao, M., Lee, H.J., Nation, R.L., Li, J., 2012, Pharmacokinetics and pharmacodynamics of 'old' polymyxins: What is new?, Diagnostic Microbiology and Infectious Disease [P], vol 74, issue 3, Elsevier Science Inc, New York, USA, pp. 213-223.

Deris, Z.Z., Yu, H., Davis, K.E., Soon, R.L., Jacob, J., Ku, K.U.C., Poudyal, A., Bergen, P.J., Tsuji, B., Bulitta, J.B., Forrest, A., Paterson, D.L., Velkov, T., Li, J., Nation, R.L., 2012, The combination of colistin and doripenem is synergistic against Klebsiella pneumoniae at multiple inocula and suppresses colistin resistance in an in vitro pharmacokinetic/pharmacodynamic model, Antimicrobial Agents And Chemotherapy [P], vol 56, issue 10, American Society for Microbiology, Washington DC, USA, pp. 5103-5112.

Bergen, P., Forrest, A., Bulitta, J., Tsuji, B., Sidjabat, H., Paterson, D., Li, J., Nation, R., 2011, Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant peudomonas aeruginosa at multiple inocula, Antimicrobial Agents And Chemotherapy [P], vol 55, issue 11, American Society for Microbiology, USA, pp. 5134-5142.

Bergen, P., McDowell, J., Elliott, R., Roller, L., Kong, D., 2011, Development of an online pharmaceutical calculations learning module, Pharmacy Education [P], vol 11, issue 1, Taylor & Francis Health Sciences, England, pp. 21-25.

Bergen, P., Li, J., Nation, R., 2011, Dosing of colistin - back to basic PK/PD, Current Opinion in Pharmacology [P], vol 11, issue 5, Elsevier, England, pp. 464-469.

Bergen, P., Tsuji, B., Bulitta, J., Forrest, A., Jacob, J., Sidjabat, H., Paterson, D., Nation, R., Li, J., 2011, Synergistic killing of multidrug-resistant pseudomonas aeruginosa at inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic model, Antimicrobial Agents And Chemotherapy [P], vol 55, issue 12, American Society for Microbiology, USA, pp. 5685-5695.

Bergen, P.J., Bulitta, J.B., Forrest, A., Tsuji, B., Li, J., Nation, R.L., 2010, Pharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro model, Antimicrobial Agents And Chemotherapy [P], vol 54, issue 9, American Society for Microbiology, United States, pp. 3783-3789.

Bergen, P.J., Li, J., Nation, R.L., Turnidge, J.D., Coulthard, K., Milne, R., 2008, Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model, Journal of Antimicrobial Chemotherapy, vol 61, issue 3, Oxford University Press, United Kingdom, pp. 636-642.

Bergen, P.J., Li, J., Rayner, C.R., Nation, R.L., 2006, Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa, Antimicrobial Agents and Chemotherapy, vol 50, issue 6, American Society for Microbiology, USA, pp. 1953-1958.

Activities

Affiliations with institutes

Drug Delivery, Disposition and Dynamics
Monash Institute of Pharmaceutical Sciences